SEC 13F Intelligence

Difesa Capital Management, LP / PACB

Difesa Capital Management, LP’s Pacific Biosciences Calif In Position

Does Difesa Capital Management, LP own Pacific Biosciences Calif In (PACB)? Not currently — the last reported position was 36.7K shares worth $488,110 in Q2 2023; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$488,110
Q2 2023
Shares
36.7K
% of Portfolio
+1.28%
Quarters Held
2
position exited

Position History PACB

Reported value by quarter
Q3 ’22: $70,000Q3 ’22Q2 ’23: $488,110Q2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202336.7K$488,110+1.28%
Q3 202212.0K$70,000+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Difesa Capital Management, LP’s full portfolio or all institutional holders of PACB.